secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2026-10-09T13:02:20+00:00
Accession:  0001628280-26-065497
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Jazz Pharmaceuticals CCO Samantha Pearce to retire by June 30, 2027; successor search launched
--------------------------------------------------------------------------------

- Executive Vice President and Chief Commercial Officer Samantha Pearce notified Jazz on Oct 6, 2026 of her intent to retire.
- Retirement takes effect upon the earlier of the selection and appointment of her successor or June 30, 2027.
- Jazz plans a formal search for a new Chief Commercial Officer, considering both internal and external candidates.
- No successor has been named; Pearce continues as CCO during the transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000162828026065497/0001628280-26-065497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000162828026065497/jazz-20261006.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-065497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer